Literature DB >> 33441342

A Potent anti-Simian Immunodeficiency Virus Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Rhesus Macaques.

Saori Matsuoka1, Takeo Kuwata2, Hiroshi Ishii1, Tsuyoshi Sekizuka3, Makoto Kuroda3, Masato Sano1, Midori Okazaki1, Hiroyuki Yamamoto1, Mikiko Shimizu4, Shuzo Matsushita4, Yohei Seki5, Akatsuki Saito5, Hiromi Sakawaki6, Vanessa M Hirsch7, Tomoyuki Miura6, Hirofumi Akari5,6, Tetsuro Matano8,4,9.   

Abstract

Virus infection induces B cells with a wide variety of B cell receptor (BCR) repertoires. Patterns of induced BCR repertoires are different in individuals, while the underlying mechanism causing this difference remains largely unclear. In particular, the impact of germ line BCR immunoglobulin (Ig) gene polymorphism on B cell/antibody induction has not fully been determined. In the present study, we found a potent antibody induction associated with a germ line BCR Ig gene polymorphism. B404-class antibodies, which were previously reported as potent anti-simian immunodeficiency virus (SIV) neutralizing antibodies using the germ line VH3.33 gene-derived Ig heavy chain, were induced in five of 10 rhesus macaques after SIVsmH635FC infection. Investigation of VH3.33 genes in B404-class antibody inducers (n = 5) and non-inducers (n = 5) revealed association of B404-class antibody induction with a germ line VH3.33 polymorphism. Analysis of reconstructed antibodies indicated that the VH3.33 residue 38 is the determinant for B404-class antibody induction. B404-class antibodies were induced in all the macaques possessing the B404-associated VH3.33 allele, even under undetectable viremia. Our results show that a single nucleotide polymorphism in germ line VH genes could be a determinant for induction of potent antibodies against virus infection, implying that germ line VH-gene polymorphisms can be a factor restricting effective antibody induction or responsiveness to vaccination.IMPORTANCE Vaccines against a wide variety of infectious diseases have been developed mostly to induce antibodies targeting pathogens. However, small but significant percentage of people fail to mount potent antibody responses after vaccination, while the underlying mechanism of host failure in antibody induction remains largely unclear. In particular, the impact of germ line B cell receptor (BCR)/antibody immunoglobulin (Ig) gene polymorphism on B cell/antibody induction has not fully been determined. In the present study, we found a potent anti-simian immunodeficiency virus neutralizing antibody induction associated with a germ line BCR/antibody Ig gene polymorphism in rhesus macaques. Our results demonstrate that a single nucleotide polymorphism in germ line Ig genes could be a determinant for induction of potent antibodies against virus infection, implying that germ line BCR/antibody Ig gene polymorphisms can be a factor restricting effective antibody induction or responsiveness to vaccination.
Copyright © 2021 American Society for Microbiology.

Entities:  

Year:  2021        PMID: 33441342      PMCID: PMC8092685          DOI: 10.1128/JVI.02455-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha.

Authors:  Ruchi M Newman; Laura Hall; Michelle Connole; Guo-Lin Chen; Shuji Sato; Eloisa Yuste; William Diehl; Eric Hunter; Amitinder Kaur; Gregory M Miller; Welkin E Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

2.  The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus.

Authors:  D A Regier; R C Desrosiers
Journal:  AIDS Res Hum Retroviruses       Date:  1990-11       Impact factor: 2.205

3.  Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120.

Authors:  Anthony P West; Ron Diskin; Michel C Nussenzweig; Pamela J Bjorkman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-27       Impact factor: 11.205

4.  HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.

Authors:  Joseph G Jardine; Daniel W Kulp; Colin Havenar-Daughton; Anita Sarkar; Bryan Briney; Devin Sok; Fabian Sesterhenn; June Ereño-Orbea; Oleksandr Kalyuzhniy; Isaiah Deresa; Xiaozhen Hu; Skye Spencer; Meaghan Jones; Erik Georgeson; Yumiko Adachi; Michael Kubitz; Allan C deCamp; Jean-Philippe Julien; Ian A Wilson; Dennis R Burton; Shane Crotty; William R Schief
Journal:  Science       Date:  2016-03-25       Impact factor: 47.728

5.  High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site.

Authors:  Christopher Sundling; Yuxing Li; Nick Huynh; Christian Poulsen; Richard Wilson; Sijy O'Dell; Yu Feng; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  Sci Transl Med       Date:  2012-07-11       Impact factor: 17.956

6.  Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population.

Authors:  Pamela Rendi-Wagner; Maria Korinek; Birgit Winkler; Michael Kundi; Herwig Kollaritsch; Ursula Wiedermann
Journal:  Vaccine       Date:  2006-09-18       Impact factor: 3.641

7.  A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.

Authors:  Laura M Walker; Melissa D Simek; Frances Priddy; Johannes S Gach; Denise Wagner; Michael B Zwick; Sanjay K Phogat; Pascal Poignard; Dennis R Burton
Journal:  PLoS Pathog       Date:  2010-08-05       Impact factor: 6.823

Review 8.  OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines.

Authors:  Nicola Cotugno; Alessandra Ruggiero; Veronica Santilli; Emma Concetta Manno; Salvatore Rocca; Sonia Zicari; Donato Amodio; Manuela Colucci; Paolo Rossi; Ofer Levy; Federico Martinon-Torres; Andrew J Pollard; Paolo Palma
Journal:  J Immunol Res       Date:  2019-04-28       Impact factor: 4.818

9.  Interactive Tree Of Life (iTOL) v4: recent updates and new developments.

Authors:  Ivica Letunic; Peer Bork
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

Review 10.  Primary vaccine failure to routine vaccines: Why and what to do?

Authors:  Ursula Wiedermann; Erika Garner-Spitzer; Angelika Wagner
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

View more
  1 in total

1.  Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Neutralization-Resistant SIVsmE543-3 Infection.

Authors:  Yuto Nomura; Saori Matsuoka; Midori Okazaki; Takeo Kuwata; Tetsuro Matano; Hiroshi Ishii
Journal:  Viruses       Date:  2021-06-21       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.